Cyclobenzaprine hydrochloride and Completed suicide - a phase IV clinical study of FDA data

Summary:

Completed suicide is reported as a side effect among people who take Cyclobenzaprine hydrochloride (cyclobenzaprine hydrochloride), especially for people who are female, 30-39 old, also take Alprazolam, and have Suicide attempt.

The study is created by eHealthMe based on reports of 7,558 people who have side effects when taking Cyclobenzaprine hydrochloride from the FDA, and is updated regularly.

What is Cyclobenzaprine hydrochloride?

Cyclobenzaprine hydrochloride has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 9,351 Cyclobenzaprine hydrochloride users. Check the latest studies of Cyclobenzaprine hydrochloride.

On Jul, 11, 2026

7,558 people reported to have side effects when taking Cyclobenzaprine hydrochloride.
Among them, 139 people (1.84%) died.

Could Cyclobenzaprine hydrochloride cause Completed suicide?

Among these 139 people:

What is the gender of people who died when taking Cyclobenzaprine hydrochloride? *

Click here to view

* Approximation only. Some reports may have incomplete information.

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cyclobenzaprine hydrochloride:

Cyclobenzaprine hydrochloride (9,351 reports)

Expand to all the drugs that have ingredients of cyclobenzaprine hydrochloride:

Completed suicide and drugs with ingredients of cyclobenzaprine hydrochloride (2,520 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cyclobenzaprine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Completed suicide:

Completed suicide (968 drugs)

Browse all the conditions that are associated with Completed suicide:

Completed suicide (1,026 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cyclobenzaprine hydrochloride (the active ingredients of Cyclobenzaprine hydrochloride) and Cyclobenzaprine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.